Foresite Capital Management IV, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Foresite Capital Management IV, LLC held in its portfolio 7 assets valued at $229,710,880 (i.e. $229.71M).

The most valuable assets in the portfolio included: Pharvaris N.V. ($132.61M), CYTOKINETICS INC ($29.12M), and Lyell Immunopharma, Inc. ($24.64M).

The chart below shows the top 7 valuable assets, and the table below shows the top 7 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Foresite Capital Management IV, LLC Portfolio

Pharvaris N.V.

CYTOKINETICS INC

Lyell Immunopharma, Inc.

Maze Therapeutics, Inc.

Relay Therapeutics, Inc.

Xenon Pharmaceuticals Inc.

Alector, Inc.

Foresite Capital Management IV, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
Pharvaris N.V.	4778581	132605623	COM
CYTOKINETICS INC	458295	29120064	COM
Lyell Immunopharma, Inc.	800399	24636281	COM
Maze Therapeutics, Inc.	522657	21653680	COM
Relay Therapeutics, Inc.	1000000	8460000	COM
Xenon Pharmaceuticals Inc.	160000	7171200	COM
Alector, Inc.	3887200	6064032	COM